Lower-cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say
Doctors say that lower-priced weight-loss pills launched in recent months by Novo Nordisk and Eli Lilly are starting to pull patients away from compounded GLP-1 alternatives. Manufacturer price cuts and broader insurance coverage are redirecting demand to the major branded drugs.
Several US endocrinology and obesity specialists told Investing.com Americas that the price gap between Novo Nordisk's lower-cost semaglutide pill, Eli Lilly's orforglipron pill, and compounded versions has narrowed enough to change patient behaviour. Manufacturers have cut monthly costs by roughly 30–40% through bundled offers and direct-to-consumer channels.
Compounded GLP-1 medicines proliferated over the past two years because of FDA shortage listings; with supply now normalised by Lilly and Novo, the agency has returned to tighter rules on preparing those formulations. Pharmacies preparing compounded versions report shipments down by more than 25%.
Analysts say the price pressure may cap Novo's and Lilly's margins, but volume growth could offset the impact. For patients, the shift means a more standardised treatment pathway; treatment decisions should always be based on individual clinical evaluation by a qualified clinician.
More from South America
The deadly 1996 plane attack at the centre of Castro's indictment
The BBC has compiled the details of the 1996 attack on civilian aircraft that lies at the centre of the US indictment against former Cuban leader Raúl Castro. Two Cessna planes belonging to the Brothers to the Rescue group were shot down off the Florida Strait, killing four people, all US citizens.
SK Hynix on track to become second Korean firm to hit $1 trillion market cap
Record demand for AI memory chips has pushed SK Hynix's market capitalisation close to the $1 trillion mark. If achieved, it would make the firm South Korea's second company to hit that level after Samsung Electronics.
Three dead after monster truck crashes into crowd
A monster truck crashed into a crowd at a show in Colombia, killing at least three people and injuring 38. The incident raises fresh concerns about public safety at large events.